We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.28T Turnover 24.66%
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+35.7%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$1.28T
AUM Growth
+$391B
Cap. Flow
+$19.1B
Cap. Flow %
1.49%
Top 10 Hldgs %
26.66%
Holding
15,023
New
1,956
Increased
5,793
Reduced
5,445
Closed
1,748
Avg Time Held Equity + Options
3.8 years
Top 10 Avg Time Held Equity + Options
5.1 years
Top 20 Avg Time Held Equity + Options
5.8 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.8 years
Top 20 Avg Time Held Equity only
3.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.8%
2 Technology 2.93%
3 Communication Services 0.62%
4 Consumer Discretionary 0.61%
5 Industrials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RLX icon
12726
RLX Technology
RLX
$1.87B
$65.6K ﹤0.01%
34,516
-171,493
-83% -$356K
2024 Q2
8 quarters
RCEL icon
12727
PUT
Avita Medical
RCEL
$478M
$65.3K ﹤0.01%
+15,800
New +$68.2K
2026 Q2
0 quarters
TLYS icon
12728
Tilly's
TLYS
$125M
$65.2K ﹤0.01%
15,524
-45,304
-74% -$205K
2024 Q2
8 quarters
OPAD icon
12729
Offerpad Solutions
OPAD
$9.3M
$65.1K ﹤0.01%
13,182
+3,817
+41% +$25.5K
2025 Q1
5 quarters
ULBI icon
12730
Ultralife
ULBI
$262M
$65.1K ﹤0.01%
10,302
-6,200
-38% -$41.8K
2024 Q3
7 quarters
TALK icon
12731
PUT
DELISTED
Talkspace
TALK
$65K ﹤0.01%
12,500
-9,300
-43% -$48.3K
2026 Q1
1 quarter
LPCN icon
12732
Lipocine
LPCN
$18M
$65K ﹤0.01%
25,376
+468
+2% +$1.12K
2021 Q3
19 quarters
BDTX icon
12733
Black Diamond Therapeutics
BDTX
$81M
$64.8K ﹤0.01%
35,011
-43,847
-56% -$107K
2025 Q4
2 quarters
PALI icon
12734
Palisade Bio
PALI
$185M
$64.6K ﹤0.01%
+30,905
New +$60.8K
2026 Q2
0 quarters
CIG icon
12735
CEMIG Preferred Shares
CIG
$5.29B
$64.6K ﹤0.01%
30,744
-22,289
-42% -$51.9K
2024 Q4
6 quarters
SOTK icon
12736
Sono-Tek
SOTK
$64.6M
$64.4K ﹤0.01%
10,522
-8,787
-46% -$42.6K
2024 Q1
9 quarters
PCM icon
12737
PCM Fund
PCM
$60.3M
$64.1K ﹤0.01%
11,482
-11,082
-49% -$63.1K
2025 Q4
2 quarters
SLMT icon
12738
Solmate Infrastructure
SLMT
$32.8M
$64K ﹤0.01%
12,657
-1,977
-14% -$12.9K
2026 Q1
1 quarter
AIRS icon
12739
AirSculpt Technologies
AIRS
$54.7M
$64K ﹤0.01%
14,214
-460,231
-97% -$1.87M
2026 Q1
1 quarter
CMTG icon
12740
Claros Mortgage Trust
CMTG
$219M
$64K ﹤0.01%
27,215
-20,189
-43% -$49.5K
2024 Q3
7 quarters
AVIR icon
12741
Atea Pharmaceuticals
AVIR
$340M
$63.8K ﹤0.01%
13,710
-68,125
-83% -$339K
2021 Q2
20 quarters
INO icon
12742
PUT
Inovio Pharmaceuticals
INO
$266M
$63.7K ﹤0.01%
57,900
-77,200
-57% -$91.6K
2025 Q2
4 quarters
MVO
12743
DELISTED
MV Oil Trust
MVO
$63.6K ﹤0.01%
35,928
+17,099
+91% +$35.7K
2023 Q4
10 quarters
RWAY icon
12744
PUT
Runway Growth Finance
RWAY
$272M
$63.4K ﹤0.01%
11,300
-1,400
-11% -$8.87K
2026 Q1
1 quarter
TASK icon
12745
PUT
TaskUs
TASK
$841M
$63.2K ﹤0.01%
13,500
-11,300
-46% -$68.6K
2026 Q1
1 quarter
ATER icon
12746
Aterian
ATER
$15.8M
$63.1K ﹤0.01%
47,818
+10,827
+29% +$11.2K
2024 Q2
8 quarters
GOSS icon
12747
Gossamer Bio
GOSS
$68.3M
$63K ﹤0.01%
4,788
+3,091
+182% +$69K
2025 Q4
2 quarters
TVRD icon
12748
Tvardi Therapeutics
TVRD
$15.1M
$63K ﹤0.01%
+33,165
New +$104K
2026 Q2
0 quarters
MVO
12749
PUT
DELISTED
MV Oil Trust
MVO
$62.5K ﹤0.01%
35,300
+21,600
+158% +$45.1K
2025 Q2
4 quarters
THCH icon
12750
TH International
THCH
$36.2M
$62.5K ﹤0.01%
32,705
+7,838
+32% +$15.2K
2025 Q2
4 quarters

Similar funds

Jeff Yass's Q2 2026 Portfolio in Review

As of Q2 2026, Jeff Yass held 15,023 positions worth $1.28T, up 44% from $893B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass's Q2 2026 filing shows 1,956 new, 5,793 increased, 5,445 reduced and 1,748 closed positions. Its largest new stake was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M. The largest sale was Invesco QQQ Trust, an estimated $1.78B.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2026 buy was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.87B increase.
  • Jeff Yass's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $1.78B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $142M.
  • Jeff Yass's ten largest holdings make up 27% of its $1.28T portfolio in Q2 2026.
  • Jeff Yass opened 1,956 new positions and closed 1,748 in Q2 2026.
  • Jeff Yass's portfolio value rose 44% quarter-over-quarter to $1.28T.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.